Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control

NCT00393458 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1732

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Indacaterol
DRUG: Formoterol
DRUG: Placebo to indacaterol
DRUG: Placebo to formoterol

Sponsor

Novartis